SOW
CTNM

State of Wyoming’s Contineum Therapeutics CTNM Stock Holding History

State of Wyoming’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Buy
+1,405
New +$18.4K ﹤0.01% 1785

Other funds holding CTNM

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State of Wyoming's CTNM Position: Q2 2026 in Review

State of Wyoming opened a new position in Contineum Therapeutics (CTNM) in Q2 2026: 1,405 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #1785 among its holdings.

102 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

  • State of Wyoming held 1,405 shares of Contineum Therapeutics worth $23K as of Q2 2026.
  • Contineum Therapeutics was a new State of Wyoming position in Q2 2026.
  • Contineum Therapeutics made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1785 holding.
  • 102 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.